0.6600
-0.0150
(-2.22%)
At close: January 31 at 8:08:15 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,040.0000
1,040.0000
-1,294.0000
-2,975.0000
-6,055.0000
Investing Cash Flow
-837.0000
-837.0000
-1,082.0000
-2,044.0000
-1,863.0000
Financing Cash Flow
-1,512.0000
-1,512.0000
910.0000
-192.0000
17,684.0000
End Cash Position
4,650.0000
4,650.0000
5,949.0000
7,709.0000
12,968.0000
Capital Expenditure
-863.0000
-863.0000
-1,090.0000
-2,047.0000
-1,866.0000
Issuance of Capital Stock
74.0000
74.0000
9.0000
--
18,669.0000
Issuance of Debt
--
--
1,708.0000
602.0000
715.0000
Free Cash Flow
177.0000
177.0000
-2,384.0000
-5,022.0000
-7,921.0000
12/31/2020 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1548.HK GENSCRIPT BIO
10.680
+1.33%
MLTX MoonLake Immunotherapeutics
45.99
-2.40%
ONVO Organovo Holdings, Inc.
0.3615
+3.61%
ACLX Arcellx, Inc.
68.13
+0.81%
SWTX SpringWorks Therapeutics, Inc.
37.50
+0.73%
LEGN Legend Biotech Corporation
38.10
+2.36%
UTHR United Therapeutics Corporation
351.17
-0.32%
SABS SAB Biotherapeutics, Inc.
2.1900
+0.92%
RCKT Rocket Pharmaceuticals, Inc.
10.74
+0.47%
ARQT Arcutis Biotherapeutics, Inc.
13.24
-3.15%